Clinical research funded by Gavi partners at Patan Hospital in Kathmandu is helping shape Nepal’s immunisation policy against its biggest child killer: pneumonia. This video shows how disease burden and impact studies at Patan have guided the national introduction of Haemophilus influenzae type b and pneumococcal vaccines, which protect children against the two main causes of pneumonia.
Gavi’s CEO Dr Seth Berkley presents an overview of the Vaccine Alliance’s achievements to the Board on 22 June 2016. Topics include results and challenges in the 2011-2015 period, early progress in implementing the 2016-2020 strategy and the role of immunisation on the global agenda.
What better way for Liberia to celebrate African Vaccination Week 2016 than with a dual celebration: the introduction of rotavirus vaccine into the national immunisation system and the launch of a human papillomavirus (HPV) vaccine demonstration project.
The Gavi Campaign is a 501(c)(3) US public charity whose charitable mission includes supporting immunization programs in developing countries. Contributions to the Gavi Campaign are managed by its Board and disbursed at the Board’s discretion, to further the mission, including programs in support of Gavi, the Vaccine Alliance.